Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04931342
Title	A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors
Acronym	BOUQUET
Recruitment	Active, not recruiting
Gender	female
Phase	Phase II
Variant Requirements	No
Sponsors	Hoffmann-La Roche
Indications	fallopian tube cancer peritoneum cancer ovarian carcinosarcoma ovary epithelial cancer malignant ovarian Brenner tumor ovarian mucinous adenocarcinoma ovarian clear cell carcinoma ovarian endometrial cancer ovarian serous carcinoma ovarian seromucinous carcinoma small-cell carcinoma of the ovary of hypercalcemic type
Therapies	Cobimetinib Ado-trastuzumab emtansine Ipatasertib + Paclitaxel Atezolizumab + Bevacizumab
Age Groups:	adult \| senior
Covered Countries	USA \| ITA \| GBR \| FRA \| ESP \| DEU \| CAN \| AUS